Journey Medical Corp
DERM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867066
No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Journey Medical Corp changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 14 | 14 | 0 |
| Shares | 1.63M | 1.64M | +16.8K (+1.0%) |
| Value | $8.76M | $7.94M | −$816.0K (−9.3%) |
New holders (5)
Institutions that held Journey Medical Corp at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Opaleye Management Inc. | 67,000 | $324.0K | 0.10% |
| Millennium Management LLC | 21,449 | $103.0K | 0.00% |
| Renaissance Technologies LLC | 15,600 | $75.0K | 0.00% |
| Plante Moran Financial Advisors, LLC | 200 | $1.00K | 0.00% |
| Wells Fargo & Company | 25 | $0 | 0.00% |
Sold out (5)
Institutions that held Journey Medical Corp at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Cannell Capital LLC | 41,108 | $221.0K |
| B. Riley Wealth Management, Inc. | 15,000 | $81.0K |
| Citadel Advisors LLC | 10,761 | $58.0K |
| Tudor Investment Corp Et Al | 10,602 | $57.0K |
| Royal Bank of Canada | 2,500 | $13.0K |